Professor Fiona Mulcahy

  2',3'-DIDEOXYINOSINE   3'-AZIDO-3'-DEOXYTHYMIDINE   ABNORMALITIES   ABT-538   ACQUIRED IMMUNODEFICIENCY SYNDROME   ACQUIRED-IMMUNODEFICIENCY-SYNDROME   ACTIVE ANTIRETROVIRAL THERAPY   ACUTE MYELOBLASTIC-LEUKEMIA   ACUTE MYELOID LEUKAEMIA   ACYCLOVIR-RESISTANT   AFRICAN ORIGIN   AIDS   ALBICANS   ANTIBODIES   ANTIFUNGAL RESISTANCE   ANTIGENS   ANTINEOPLASTIC AGENTS   ANTIRETROVIRAL THERAPY   ARBITRARY PRIMERS   ASPERGILLOSIS   ATTITUDES   AUTOPSY   AVIUM COMPLEX INFECTION   AZIDOTHYMIDINE   AZT   BEHAVIOR   BETA-LYSIN   BINDING DISPLACEMENT INTERACTIONS   BISEXUAL MEN   BLEOMYCIN   BLOOD-DONORS   BLOODSTREAM INFECTION   CALCIFICATION   CANCER   CANDIDA   CANDIDA DUBLINIENSIS   CANDIDIASIS   CATHETERS   CD4 CELL COUNTS   CD4 CELLS   CELL COUNTS   CELL LEUKEMIA-VIRUS   CENTRAL-NERVOUS-SYSTEM   CERVICAL SMEARS   CHROMAGAR CANDIDA   CLINICAL ENTITY   CLINICAL-TRIALS   CLUSTER   COBALAMIN DEFICIENCY   COHORT   COMBINATION   COMBINATION THERAPY   COMPLEX   CONTAINING REGIMEN   CONTROLLED TRIAL   CUBIC MILLIMETER   CUTANEOUS   CYCLOSPORINE-A   CYP3A4   CYTOMEGALOVIRUS   DAPSONE   DEFINING ILLNESSES   DEHYDROGENASE LEVELS   DEPRESSION   DIDANOSINE   DIGOXIN   DISEASE   DISEASE PROGRESSION   DNA TYPING METHODS   DOUBLE-BLIND   DRUG RESISTANCE   DRUG-INTERACTIONS   DUBLIN   ELECTROPHORETIC KARYOTYPE   ENZYME-INDUCTION   FACTOR-VIII   FEMALE PROSTITUTES   FLOW CYTOMETRY   FOSCARNET   GEL-ELECTROPHORESIS   GENITAL-TRACT   GENOTYPE   GENOTYPIC RESISTANCE   GUM ATTENDERS   HAEMOPHILIA   HEMOPHILIA   HEPATITIS B   HERPES-SIMPLEX VIRUS   HIV   HIV INFECTION   HIV PROTEASE INHIBITORS   HIV-1 DRUG SUSCEPTIBILITY   HIV-INFECTED PATIENTS   HIV-INFECTION   HTLV-II   HUMAN PAPILLOMAVIRUS INFECTION   HUMAN-IMMUNODEFICIENCY-VIRUS   HYPERICUM-PERFORATUM   I-ASSOCIATED MYELOPATHY   IMMUNE-DEFICIENCY-SYNDROME   IMMUNODEFICIENCY-VIRUS INFECTION   INDIVIDUALS   INFECTION   INHIBITOR   IRELAND   KAPOSI'S SARCOMA   KNOWLEDGE   LYMPHOMA VIRUS   MALIGNANCIES   MDR1   MORTALITY   NON-HODGKIN'S LYMPHOMA   NORTH-AMERICA   NUCLEAR RECEPTOR   PATIENT   P-GLYCOPROTEIN   PHONOTYPE   PLACEMENT   PNEUMOCYSTIS CARINII   PNEUMOCYSTIS-CARINII PNEUMONIA   PNEUMONIA   PREGNANE-X RECEPTOR   PROPHYLAXIS   PROTEASE   PROTEASE INHIBITOR   PROTEASE INHIBITOR THERAPY   PROTEASE INHIBITORS   RAPID IDENTIFICATION   REDUCED SENSITIVITY   REVERSE TRANSCRIPTASE INHIBITORS   REVERSE-TRANSCRIPTASE INHIBITORS   RITONAVIR   SAQUINAVIR PHARMACOKINETICS   SAQUINAVIR-NELFINAVIR INTERACTION   SARCOMA   SCROTUM   SPECTRUM   ST JOHN'S WORT   SUBTYPE-B   SURVIVAL   SUSCEPTIBILITY   THYROID   TROPICAL SPASTIC PARAPARESIS   USERS   VIROLOGICAL RESPONSE   VIRUS-INFECTED PATIENTS   VIRUS-RELATED LYMPHOMA   WOMENS ATTITUDES   ZIDOVUDINE-RESISTANCE